Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Munn

Showing results (81-90 of 185) with videos related to

Pageof 19
Sort By:
Blood|December 14, 2007
Indoleamine 2,3-dioxygenase is a critical regulator of acute graft-versus-host disease lethalityLisa K Jasperson, Christoph Bucher, Angela Panoskaltsis-Mortari, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 12, 2014
TLR2-dependent activation of β-catenin pathway in dendritic cells induces regulatory responses and attenuates autoimmune inflammationIndumathi Manoharan, Yuan Hong, Amol Suryawanshi, et al.
Cell Reports|September 29, 2015
Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent MannerRikke B Holmgaard, Dmitriy Zamarin, Yanyun Li, et al.
Journal for Immunotherapy of Cancer|April 5, 2025
β-blocker suppresses both tumoral sympathetic neurons and perivascular macrophages during oncolytic herpes virotherapyKonstantina Kyritsi, Rafal Pacholczyk, Eugene Douglass, et al.
Journal for Immunotherapy of Cancer|October 14, 2020
p50 suppresses cytotoxic T lymphocyte effector function to regulate tumor immune escape and response to immunotherapyChunwan Lu, John D Klement, Alyssa D Smith, et al.
Molecular and Cellular Biology|November 20, 2013
GCN2-dependent metabolic stress is essential for endotoxemic cytokine induction and pathologyHaiyun Liu, Lei Huang, Jillian Bradley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2003
Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansionAndrew L Mellor, Babak Baban, Phillip Chandler, et al.
International Immunology|June 22, 2005
A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type I IFN signaling following B7 ligationBabak Baban, Anna M Hansen, Phillip R Chandler, et al.
International Journal of Cancer|September 5, 2002
Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejectionMaria Friberg, Ronald Jennings, Marwan Alsarraj, et al.
Neuro-Oncology Advances|June 27, 2025
Brain CD73 modulates interferon signaling to regulate glioblastoma invasionKonstantina Kyritsi, Jishi Ye, Eugene Douglass, et al.
Pageof 19

Showing results (81-90 of 185) with videos related to

Sort By:
Pageof 19
Blood|December 14, 2007
Indoleamine 2,3-dioxygenase is a critical regulator of acute graft-versus-host disease lethalityLisa K Jasperson, Christoph Bucher, Angela Panoskaltsis-Mortari, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 12, 2014
TLR2-dependent activation of β-catenin pathway in dendritic cells induces regulatory responses and attenuates autoimmune inflammationIndumathi Manoharan, Yuan Hong, Amol Suryawanshi, et al.
Cell Reports|September 29, 2015
Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent MannerRikke B Holmgaard, Dmitriy Zamarin, Yanyun Li, et al.
Journal for Immunotherapy of Cancer|April 5, 2025
β-blocker suppresses both tumoral sympathetic neurons and perivascular macrophages during oncolytic herpes virotherapyKonstantina Kyritsi, Rafal Pacholczyk, Eugene Douglass, et al.
Journal for Immunotherapy of Cancer|October 14, 2020
p50 suppresses cytotoxic T lymphocyte effector function to regulate tumor immune escape and response to immunotherapyChunwan Lu, John D Klement, Alyssa D Smith, et al.
Molecular and Cellular Biology|November 20, 2013
GCN2-dependent metabolic stress is essential for endotoxemic cytokine induction and pathologyHaiyun Liu, Lei Huang, Jillian Bradley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2003
Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansionAndrew L Mellor, Babak Baban, Phillip Chandler, et al.
International Immunology|June 22, 2005
A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type I IFN signaling following B7 ligationBabak Baban, Anna M Hansen, Phillip R Chandler, et al.
International Journal of Cancer|September 5, 2002
Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejectionMaria Friberg, Ronald Jennings, Marwan Alsarraj, et al.
Neuro-Oncology Advances|June 27, 2025
Brain CD73 modulates interferon signaling to regulate glioblastoma invasionKonstantina Kyritsi, Jishi Ye, Eugene Douglass, et al.
Pageof 19